Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Advances in Microarray Technology
Conferences  \  Advances in Microarray Technology  \  Agenda  \  Ulrike Korf
RegisterLogin

Ulrike Korf's Biography


Ulrike Korf, Senior Scientist/Group Leader, German Cancer Research Center

Dr. Ulrike Korf has established reverse phase protein arrays (RPPA) at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. She is using this RPPA as technology for targeted proteomics and in various projects ranging from biomarker discovery over drug validation to systems biology approaches.

Ulrike Korf Image

Identification of a Protein Biomarker Signature Using Reverse Phase Protein Arrays (RPPA) for Risk Classification of Estrogen Receptor-Positive Breast Cancer

Tuesday, 5 March 2013 at 11:15

Add to Calendar ▼2013-03-05 11:15:002013-03-05 12:15:00Europe/LondonIdentification of a Protein Biomarker Signature Using Reverse Phase Protein Arrays (RPPA) for Risk Classification of Estrogen Receptor-Positive Breast Cancer Advances in Microarray Technology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

Using reverse phase protein arrays (RPPA) a protein signature was identified that can distinguish between high and low risk luminal breast cancer.

Add to Calendar ▼2013-03-05 00:00:002013-03-06 00:00:00Europe/LondonAdvances in Microarray TechnologyAdvances in Microarray Technology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com


Conference Sponsors
Related Conferences
Point-of-Care, Biosensors and Rapid Dx Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024


Liquid Biopsy 2024: Technologies & Applications
Location: Ann Arbor, Michigan
Date: 06/05/2024 - 07/05/2024


Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024
Location: New Orleans
Date: 26/09/2024 - 27/09/2024